Nobuko Kawazoe

746 total citations
9 papers, 670 citations indexed

About

Nobuko Kawazoe is a scholar working on Molecular Biology, Toxicology and Pharmacology. According to data from OpenAlex, Nobuko Kawazoe has authored 9 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Toxicology and 1 paper in Pharmacology. Recurrent topics in Nobuko Kawazoe's work include Bioactive Compounds and Antitumor Agents (3 papers), Cancer therapeutics and mechanisms (2 papers) and interferon and immune responses (1 paper). Nobuko Kawazoe is often cited by papers focused on Bioactive Compounds and Antitumor Agents (3 papers), Cancer therapeutics and mechanisms (2 papers) and interferon and immune responses (1 paper). Nobuko Kawazoe collaborates with scholars based in Japan. Nobuko Kawazoe's co-authors include Kazuyasu Nakaya, Shigeo Nakajo, Yutaka Masuda, Takemi Yoshida, Yukio Kuroiwa, Masahiko Watabe, Yoshiro Otsuki, Masamitsu Tanaka, Shigeto Yoshii and Haruhiko Sugimura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and The Journal of Biochemistry.

In The Last Decade

Nobuko Kawazoe

9 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuko Kawazoe Japan 7 553 86 71 68 58 9 670
Wen-Wen Huang Taiwan 16 469 0.8× 70 0.8× 60 0.8× 78 1.1× 50 0.9× 19 700
Binbin Lu China 14 547 1.0× 48 0.6× 75 1.1× 97 1.4× 23 0.4× 27 849
Rishi K. Gara India 12 323 0.6× 40 0.5× 83 1.2× 98 1.4× 31 0.5× 12 594
Jonathan Michaud‐Levesque Canada 12 568 1.0× 95 1.1× 18 0.3× 96 1.4× 51 0.9× 15 859
Wen-Liang Chang Taiwan 10 298 0.5× 49 0.6× 45 0.6× 70 1.0× 24 0.4× 11 626
Meng-Wei Lin Taiwan 12 374 0.7× 57 0.7× 82 1.2× 66 1.0× 41 0.7× 12 650
F O Ranelletti Italy 14 256 0.5× 57 0.7× 28 0.4× 76 1.1× 109 1.9× 25 550
Robert E. Gerl Australia 6 447 0.8× 47 0.5× 26 0.4× 134 2.0× 34 0.6× 8 701
Yanmin Dong China 13 337 0.6× 43 0.5× 72 1.0× 81 1.2× 37 0.6× 19 617
Ravindra Kamath India 11 520 0.9× 125 1.5× 71 1.0× 125 1.8× 20 0.3× 11 719

Countries citing papers authored by Nobuko Kawazoe

Since Specialization
Citations

This map shows the geographic impact of Nobuko Kawazoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuko Kawazoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuko Kawazoe more than expected).

Fields of papers citing papers by Nobuko Kawazoe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuko Kawazoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuko Kawazoe. The network helps show where Nobuko Kawazoe may publish in the future.

Co-authorship network of co-authors of Nobuko Kawazoe

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuko Kawazoe. A scholar is included among the top collaborators of Nobuko Kawazoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuko Kawazoe. Nobuko Kawazoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Otsuki, Yoshiro, Masamitsu Tanaka, Shigeto Yoshii, et al.. (2001). Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proceedings of the National Academy of Sciences. 98(8). 4385–4390. 159 indexed citations
2.
Kawazoe, Nobuko, Masahiko Watabe, Yutaka Masuda, Shigeo Nakajo, & Kazuyasu Nakaya. (1999). Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells. Oncogene. 18(15). 2413–2421. 105 indexed citations
3.
Kawazoe, Nobuko, Toshihiro Aiuchi, Yutaka Masuda, Shigeo Nakajo, & Kazuyasu Nakaya. (1999). Induction of Apoptosis by Bufalin in Human Tumor Cells Is Associated with a Change of Intracellular Concentration of Na+ Ions. The Journal of Biochemistry. 126(2). 278–286. 43 indexed citations
4.
Hashimoto, Sachiko, Yongkui Jing, Nobuko Kawazoe, et al.. (1997). Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leukemia Research. 21(9). 875–883. 98 indexed citations
5.
Watabe, Masahiko, Nobuko Kawazoe, Yutaka Masuda, Shigeo Nakajo, & Kazuyasu Nakaya. (1997). Bcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activation in human leukemia U937 cells.. PubMed. 57(15). 3097–100. 63 indexed citations
6.
Masuda, Yutaka, Nobuko Kawazoe, Shigeo Nakajo, et al.. (1995). Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leukemia Research. 19(8). 549–556. 112 indexed citations
7.
Jing, Yongkui, Nobuko Kawazoe, Sachiko Hashimoto, et al.. (1994). Selective Inhibitory Effect of Bufalin on Growth of Human Tumor Cells in vitro: Association with the Induction of Apoptosis in Leukemia HL‐60 Cells. Japanese Journal of Cancer Research. 85(6). 645–651. 87 indexed citations
8.
Kawazoe, Nobuko, et al.. (1993). [Relationship between the Ki-67 nuclear antigen content and cell-cycle perturbation on WiDr cells treated with 5-FU].. PubMed. 6(2). 121–5. 1 indexed citations
9.
Ishikawa, H., et al.. (1989). [Study of fluorescence in situ hybridization for detection of chromosome aberration].. PubMed. 2(4). 436–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026